Position in NKTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$171,138
+$37,153 QoQ
Shares Held
60,473
-4.8% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 136 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 21%
Shared 0%
None 79%
Common Shares in NKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. NKTX ranks #254 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in NKTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $171,138 | 60,473 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $133,985 | 63,500 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $123,927 | 66,988 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $146,471 | 70,759 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $130,346 | 78,522 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $143,860 | 78,185 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $202,165 | 81,191 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $357,333 | 79,056 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $496,505 | 84,011 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $550,164 | 50,894 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $325,578 | 49,330 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $68,568 | 49,330 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $108,466 | 49,528 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $181,887 | 51,236 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $309,593 | 51,685 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $669,054 | 50,840 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $591,741 | 48,031 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $203,906 | 17,918 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $300,384 | 19,569 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $558,341 | 20,077 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $614,849 | 19,402 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $686,623 | 20,870 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,143,157 | 18,597 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $462,863 | 15,398 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||